
Episode 118: Amar Sawhney, General Partner of Incept & CEO of Instylla and Rejoni | Brains, Sweat and Money: Self-Funding and Raising Capital for 25 Startups
Medtech Money
00:00
How I Survived the Pain of Losing My Platform Technology From My First Acquisition
FOCO was acquired by Genzyme, a company that has been around since the 1970s. FOCO started out as an engineering graduate student working on surgical sealants to be able to seal leaks from tissue. The technology they created is now used in growing organs and 3D printing. But it took them years to get FDA approval for their lung sealant.
Transcript
Play full episode